Literature DB >> 29743419

Metabolic Syndrome and the Risk of New-Onset Atrial Fibrillation in Middle-Aged East Asian Men.

Yong-Giun Kim1, Kee-Joon Choi2, Seungbong Han3, Ki Won Hwang4, Chang Hee Kwon5, Gyung-Min Park1, Ki-Bum Won1, Soe Hee Ann1, Jun Kim2, Shin-Jae Kim1, Sang-Gon Lee1, Gi-Byoung Nam2, You-Ho Kim2.   

Abstract

BACKGROUND: Although the prevalence of both atrial fibrillation (AF) and metabolic syndrome (MetS) has been increasing in East Asia, the association between them is uncertain.Methods and 
Results: A total of 24,741 middle-aged Korean men without baseline AF were enrolled in a health screening program from January 2003 to December 2008. Among them, 21,981 subjects were evaluated to determine the risk of AF based on baseline MetS status through December 2016. At every visit, the subjects were evaluated for AF using ECG. MetS was defined using the criteria of the International Diabetes Federation and was present in 2,529 subjects (11.5%). Mean (±standard deviation) age was 45.9±5.3 years. During a mean follow-up of 8.7 years, 168 subjects (0.8%) were diagnosed with AF. The age-adjusted and multivariate-adjusted hazard ratios (HR) for MetS with AF were 1.62 (P=0.02) and 1.57 (P=0.03), respectively. Among the components of MetS, central obesity (age-adjusted HR 1.62, P<0.01) and raised blood pressure (age-adjusted HR 1.43, P=0.02) were associated with an increased risk of AF.
CONCLUSIONS: MetS is associated with an increased risk of AF in middle-aged East Asian men. Of the components of MetS, central obesity is the most potent risk factor for the development of AF in this population.

Entities:  

Keywords:  Atrial fibrillation; Central obesity; Metabolic syndrome; Risk factors

Mesh:

Year:  2018        PMID: 29743419     DOI: 10.1253/circj.CJ-18-0113

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  10 in total

1.  QTc Interval is Associated with Atrial Fibrillation in Individuals with Metabolic Syndrome Phenotype.

Authors:  Ming-Chuan Lee; Yu-Tsang Wang; Yu-Ju Li; Ching-Yi Tsai; Su-Te Chen; Wun-Jyun Jhuang; Meng-Chi Chang; Mei-Yu Chien; Hsiang-Chun Lee
Journal:  Int J Gen Med       Date:  2022-07-15

2.  Long-term metabolic fate and mortality in obesity without metabolic syndrome.

Authors:  Aki Juhani Käräjämäki; Arto Korkiakoski; Janne Hukkanen; Y Antero Kesäniemi; Olavi Ukkola
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

3.  Risk prediction for new-onset atrial fibrillation using the Minnesota code electrocardiography classification system.

Authors:  Yu Igarashi; Kotaro Nochioka; Yasuhiko Sakata; Tokiwa Tamai; Shinya Ohkouchi; Toshiya Irokawa; Hiromasa Ogawa; Hideka Hayashi; Takahide Fujihashi; Shinsuke Yamanaka; Takashi Shiroto; Satoshi Miyata; Jun Hata; Shogo Yamada; Toshiharu Ninomiya; Satoshi Yasuda; Hajime Kurosawa; Hiroaki Shimokawa
Journal:  Int J Cardiol Heart Vasc       Date:  2021-03-31

4.  Obesity phenotypes and their relationships with atrial fibrillation.

Authors:  Szu-Ying Tsai; Hsin-Hao Chen; Hsin-Yin Hsu; Ming-Chieh Tsai; Le-Yin Hsu; Lee-Ching Hwang; Kuo-Liong Chien; Chien-Ju Lin; Tzu-Lin Yeh
Journal:  PeerJ       Date:  2021-10-28       Impact factor: 2.984

5.  Impact of thyroid disease in patients with atrial fibrillation: Analysis from the JoFib registry.

Authors:  Hanna Al-Makhamreh; Abdallah Al-Ani; Dana Alkhulaifat; Liza Shaban; Neveen Salah; Rusul Almarayaty; Yazan Al-Huneidy; Ayman Hammoudeh
Journal:  Ann Med Surg (Lond)       Date:  2022-01-29

6.  Non-alcoholic Fatty Liver Disease and the Risk of Incident Atrial Fibrillation in Young Adults: A Nationwide Population-Based Cohort Study.

Authors:  JungMin Choi; So-Ryoung Lee; Eue-Keun Choi; Hyo-Jeong Ahn; Soonil Kwon; Sang-Hyeon Park; HuiJin Lee; Jaewook Chung; MinJu Han; Seung-Woo Lee; Kyung-Do Han; Seil Oh; Gregory Y H Lip
Journal:  Front Cardiovasc Med       Date:  2022-03-23

7.  Shensong Yangxin Protects Against Metabolic Syndrome-Induced Ventricular Arrhythmias by Inhibiting Electrical Remodeling.

Authors:  Hong-Jie Yang; Bin Kong; Wei Shuai; Jing-Jing Zhang; He Huang
Journal:  Front Pharmacol       Date:  2020-07-09       Impact factor: 5.810

Review 8.  The Pathogenic Role of Very Low Density Lipoprotein on Atrial Remodeling in the Metabolic Syndrome.

Authors:  Hsiang-Chun Lee; Yi-Hsiung Lin
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

9.  The role of postprandial very-low-density lipoprotein in the development of atrial remodeling in metabolic syndrome.

Authors:  Hsiang-Chun Lee; Shyi-Jang Shin; Jih-Kai Huang; Ming-Yen Lin; Yu-Hsun Lin; Liang-Yin Ke; He-Jiun Jiang; Wei-Chung Tsai; Min-Fang Chao; Yi-Hsiung Lin
Journal:  Lipids Health Dis       Date:  2020-09-22       Impact factor: 3.876

Review 10.  Relationship between lipoproteins, thrombosis, and atrial fibrillation.

Authors:  Wern Yew Ding; Majd B Protty; Ian G Davies; Gregory Y H Lip
Journal:  Cardiovasc Res       Date:  2022-02-21       Impact factor: 10.787

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.